Eligibility for COVID treatment (April 11, 2022)
This form will provide you with guidance as to whether your patient is (or you are) eligible for government-approved COVID-19 treatments such as monoclonal antibody therapy (intravenous) or nirmatrelvir/ritonavir (Paxlovid - oral pills). It is based on the Ontario Covid-19 Drugs and Biologics Clinical Practice Guidelines Working Group: Therapeutic Management of Adult Patients with Covid-19 - updated Feb 23, 2022:  https://doi.org/10.47326/ocsat.cpg.2022.10.0 
Please note: This may not be comprehensive and may not be applicable to every patient's situation - Health care professionals should use their own clinical judgment, and patients should reach out to a health care professional with any questions. Based on the document, there are priority populations that should be considered for access to Covid-19 drugs and therapeutics.   (Google form developed by Dr. Sohal Goyal)
Sign in to Google to save your progress. Learn more
Please answer this question to help us with future development.  Why are you using this form? *
Clear form
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy